A common carcinogen benzo[a]pyrene causes p53 overexpression in mouse cervix via DNA damage

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 724, Issue 1-2, 2011, Pages 69-75

  Gao, Meili ^a   Li, Yongfei ^b   Sun, Ying ^a   Long, Jiangang ^a   Kong, Yu ^a   Yang, Shuiyun ^a   Wang, Yili ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b XI'AN TECHNOLOGICAL UNIVERSITY   (China)

Author keywords

Benzo a pyrene; Cervix; DNA damage; P53

Indexed keywords

BENZO[A]PYRENE; MESSENGER RNA; PROTEIN P53;

ANIMAL TISSUE; ARTICLE; COMET ASSAY; CYTOTOXICITY; DNA DAMAGE; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX;

ANIMALS; BENZO(A)PYRENE; CARCINOGENS; CELLS, CULTURED; CERVIX UTERI; DNA DAMAGE; FEMALE; GENES, P53; MICE; MICE, INBRED ICR; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

ANIMALIA; MUS;

EID: 79960990343     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.06.008     Document Type: Article

References (56)

1. Cheu J., Talaska G., Miller M., Rice C., Warshawsky D. Benzo[a]pyrene coated ferric oxide and aluminium oxide particles: uptake, metabolism and DNA binding in hamster pulmonary alveolar macrophages and tracheal epithelial cells in vitro. Carcinogenesis 1997, 18:167-175.
2. Cavalieri E.L., Rogan E.G. Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 1995, 25:677-688.
3. Kim K.B., Lee B.M. Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo[a]pyrene. Cancer Lett. 1997, 113:205-212.
4. Lewis D.F., Ioannides C., Parke D.V. Molecular modelling of cytochrome CYP1A1: a putative access channel explains differences in induction potency between the isomers benzo(a)pyrene and benzo(e)pyrene, and 2- and 4-acetylaminofluorene. Toxicol. Lett. 1994, 71:235-243.
5. Han E.H., Kim H.G., Im J.H., Jeong T.C., Jeong H.G. Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium. Toxicology 2009, 266:38-47.
6. Kim H.S., Kwack S.J., Lee B.M. Lipid peroxidation, antioxidant enzymes, and benzo[a]pyrene-quinones in the blood of rats treated with benzo[a]pyrene. Chem. Biol. Interact. 2000, 127:139-150.
7. Hemminki K. DNA adducts in biomonitoring. Toxicol. Lett. 1995, 77:227-229.
8. Krokan H.E., Nilsen H., Skorpen F., Otterlei M., Slupphaug G. Base excision repair of DNA in mammalian cells. FEBS Lett. 2000, 476:73-77.
9. 3) enhances benzo[a]pyrene genotoxicity in endotracheally treated rat, as determined by comet assay. Mutat. Res. 2003, 538:19-29.
10. Mounho B.J., Burchiel S.W. Alterations in human B cell calcium homeostasis by polycyclic aromatic hydrocarbons: possible associations with cytochrome P450 metabolism and increased protein tyrosine phosphorylation. Toxicol. Appl. Pharmacol. 1998, 149:80-89.
11. Huang L.W., Chou Y.Y., Chao S.L., Chen T.J., Lee T.T. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome. Gynecol. Oncol. 2001, 83:348-354.
12. Brys M., Semczuk A., WoÂjcik M., Krajewska W.M., Jakowicki J.A. p53 protein detection by the Western blotting technique in normal and neoplastic specimens of human endometrium. Cancer Lett. 2000, 148:197-205.
13. Waggoner S.E., Anderson S.M., Luce M.C., Takahashi H., Boyd J. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol. Oncol. 1996, 60:339-344.
14. Lai T.J., Tsai Y.Y., Cheng Y.W., Chiang C.C., Lee H., Chou M.C., Chang J.H. An association between BPDE-like DNA adduct levels and P53 gene mutation in pterygium. Mol. Vis. 2006, 12:1687-1691.
15. Ueda M., Hung Y.C., Terai Y., Saito J., Nunobiki O., Noda S., Ueki M. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis. Gynecol. Oncol. 2005, 96:736-740.
16. Alam S., Conway M.J., Chen H.S., Meyers C. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J. Virol. 2008, 1:1053-1058.
17. Odongua N., Chae Y.M., Kim M.R., Yun J.E., Jee S.H. Associations between smoking, screening, and death caused by cervical cancer in Korean women. Yousei Med. J. 2007, 48:192-200.
18. Holschneider C.H., Baldwin R.L., Tumber K., Aoyama C., Karlan B.Y. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer. Clin. Cancer Res. 2005, 11:5756-5763.
19. Melikian A.A., Sun P., Prokopczyk B., El-Bayoumy K., Hoffmann D., Wang X., Waggoner S. Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography mass spectrometry. Cancer Lett. 1999, 146:127-134.
20. Ambalavanan N., Carlo W.F., Bulger A., Shi J., Philips J.B. Effect of cigarette smoke extract on neonatal porcine vascular smooth muscle cells. Toxicol. Appl. Pharmacol. 2001, 170:130-136.
21. Garry S., Nesslany F., Aliouat E., Haguenoer J.M., Marzin D. Assessment of genotoxic effect of benzo[a]pyrene in endotracheally treated rat using the comet assay. Mutat. Res. 2003, 534:33-43.
22. Hellman B., Vaghef H., Boström B. The concepts of tail moment and tail inertia in the single-cell gel electrophoresis assay. Mutat. Res. 1995, 336:123-131.
23. Singh N.P., Mccoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
24. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. The single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
25. Fernandes A.O., Banerji A.P. The field bean protease inhibitor can effectively suppress 7,12-dimethylbenz[a]anthracene-induced skin tumori-genesis in mice. Cancer Lett. 1996, 104:219-224.
26. Lahiri M., Bhide S.V. Effect of four plant phenols, β-carotene and α-tocopherol on 3(H)benzopyrene-DNA interaction in vitro in the presence of rat and mouse liver postmitochondrial fraction. Cancer Lett. 1993, 73:35-39.
27. Gu Q.H., Hu C.P., Chen Q., Xia Y., Feng J.T., Yang H.Z. Development of a rat model by 3,4-benzopyrene intra-pulmonary injection and evaluation of the effect of green tea drinking on p53 and bcl-2 expression in lung carcinoma. Cancer Detect. Prev. 2009, 32:444-451.
28. Jeong H.J., Kimb H.J., Seo I.Y., Kimc H.J., Oh G.J., Chae S.C., Lim J.S., Chung H.T., Kim J.J. Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett. 2003, 202:193-199.
29. Amresh G., Rao C.V., Singh P.N. Antioxidant activity of Cissampelos pareira on benzo(a)pyrene-induced mucosal injury in mice. Nutr. Res. 2007, 27:625-632.
30. Okereke C.S., Barat S.A., Abdel-Rahman M.S. Safety evaluation of benzophenone-3 after dermal administration in rats. Toxicol. Lett. 1995, 80:61-67.
31. Burdick A.D., Davis J.W., Liu K.J., Hudson L.G., Shi H., Monske M.L., Burchiel S.W. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res. 2003, 63:7825-7833.
32. Carrozzino R., Puglia C.P., Carli A., Mariottini G.L., Martelli A. Alkaline single-cell gel electrophoresis assay of actina equine for monitoring seawater genotoxicity. Bull. Environ. Contam. Toxicol. 2004, 72:7-12.
33. Yang Y., Griffiths W.J., Nordling M., Nygren J., Möller L., Bergman J., Liepinsh E., Otting G., Gustafsson J.Å., Rafter J., Sjövall J. Ring opening of benzo[a]pyrene in the germ-free rat is a novel pathway for formation of potentially genotoxic metabolites. Biochemistry 2000, 39:15585-15591.
34. Myllynen P., Kurttila T., Vaskivuo L., Vähäkangas K. DNA damage caused by benzo(a)pyrene in MCF-7 cells is increased by verapamil, probenecid and PSC833. Toxicol. Lett. 2007, 169:3-12.
35. Gao M.L., Long J.G., Li Y.F., Shah W., Fu L., Liu J.K., Wang Y.L. Mitochondrial decay is involved in BaP-induced cervical damage. Free Radic. Biol. Med. 2010, 49:1735-1745.
36. Gao M.L., Li Y.F., Long J.G., Shah W., Fu L., Wang Y.L. Induction of oxidative stress and DNA damage in cervix in acute treatment with benzo[a]pyrene. Mutat. Res. 2011, 719:52-59.
37. Manju V., Sailaja J.K., Nalini N. Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. Clin. Biochem. 2002, 35:621-625.
38. Beevi S.S., Rasheed M.H., Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin. Chim. Acta 2007, 375:119-123.
39. Srivastava S., Natu S.M., Gupta A., Pal K.A., Singh U., Agarwal G.G., Singh U., Goel M.M., Srivastava A.N. Lipid peroxidation an antioxidants in different stages of cervical cancer: prognostic significance. Indian J. Cancer 2009, 46:297-302.
40. Uchiyama M., Iwasaka T., Matsuoa N., Hachisuga T., Mori M., Sugimori H. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Gynecol. Oncol. 1997, 65:23-29.
41. Garzetti G.G., Ciavattini A., Lucarini G., Goteri G., Nictolis M.D., Romanini C., Biagini G. Modulation of expression of p53 and cell proliferation in locally advanced cervical carcinoma after neoadjuvant combination chemotherapy. Eur. J. Obstet. Gynecol. Reprod. Biol. 1995, 63:31-36.
42. Ebara T., Mitsuhashi N., Saito Y., Sakurai H., Hasegawa M., Takahashi M., Takahashi T., Hayakwa K., Niibe H. Prognostic significance of immuno-histochemically detected p53 protein expression in stage III B squamous cell carcinoma of the uterine cervix treated with radiation therapy alone. Gynecol. Oncol. 1996, 63:216-218.
43. Benjamin C.L., Ananthaswamy H.N. p53 and the pathogenesis of skin cancer. Toxicol. Appl. Pharmacol. 2007, 224:241-248.
44. Strano S., Dell'Orso S., Mongiovi A.M., Monti O., Lapi E., Di Agostino S., Fontemaggi G., Blandino G. Mutant p53 proteins: between loss and gain of function. Head Neck 2007, 29:488-496.
45. Cheung K.J., Horsman D.E., Gascoyne R.D. The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target. Br. J. Haematol. 2009, 146:257-269.
46. Ngan H.Y., Liu S.S., Yu H., Liu K.L., Cheung A.N. Proto- oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia. Eur. J. Cancer 1999, 35:1546-1550.
47. Dimitrakakis C., Kymionis G., Diakomanolis E., Papaspyrou I., Rodolakis A., Arzimanoglou I., Leandros E., Michalas S. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol. Oncol. 2000, 77:129-136.
48. Rämet M., Castrén K., Järvinen K., Pekkala K., Turpeenniemi-Hujanen T., Soini Y., Pääkkö P., Vähäkangas K. p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis 1995, 16:2117-2124.
49. Stierum R.H., van Herwijnen M.H., Pasman P.C., Hageman G.J., Kleinjans J.C., van Agen B. Inhibition of poly(ADP-ribose) polymerase increases (+/-)-anti-benzo [a]pyrene diolepoxide-induced micronuclei formation and p53 accumulation in isolated human peripheral blood lymphocytes. Carcinogenesis 1995, 16:2765-2771.
50. Berlin Grace V.M., Veronica Shalini J., Sree lekha T.T., Niranjali Devaraj S., Devaraj H. Co-overexpression of p53 and bcl-2 proteins in HPV- induced squamous cell carcinoma of the uterine cervix. Gynecol. Oncol. 2003, 91:51-58.
51. Iskander K., Gaikwad A., Paquet M., Long D.J., Brayton C., Barrios R., Jaiswal A.K. Lower induction of p53 and decreased apoptosis in NQO1-Null mice lead to increased sensitivity to chemical-induced skin carcinogenesis. Cancer Res. 2005, 65:2054-2058.
52. Kakinumaa S., Nishimura M., Kubo A., Nagai J., Amasaki Y., Majima H.J., Sado T., Shimada Y. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas. Mutat. Res. 2005, 572:132-141.
53. Oka K., Suzuki Y., Iida H., Nakano T. Radiation therapy induces the p53(+)p21(-) expression in squamous cell carcinomas of the uterine cervix. Gynecol. Oncol. 2004, 93:340-344.
54. Park S.Y., Lee S.M., Ye S.K., Yoon S.H., Chung M.H., Choi J. Benzo[a]pyrene-induced DNA damage and p53 modulation in human hepatoma HepG2 cells for the identification of potential biomarkers for PAH monitoring and risk assessment. Toxicol. Lett. 2006, 167:27-33.
55. Hussain S.P., Harris C.C. p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat. Res. 1999, 428:23-32.
56. Ozaki T., Nakagawara A. p53: the attractive tumor suppressor in the cancer research field. J. Biomed. Biotechnol. 2011, 10.1155/2011/603925.